Clinical Trial

High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI

Name: High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI — clinical trial record (NCT06924684)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HEROS-PCI

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated April 11, 2025 (before its estimated June 23, 2025 completion). Its status may not reflect the trial's current state.

Summary

To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days

Trial Details

NCT Number	NCT06924684
Lead Sponsor	Sheikh Zayed Federal Postgraduate Medical Institute Collaborators: Punjab Institute of Cardology
Conditions	ST Elevation (STEMI) Myocardial Infarction
Enrollment	66 participants
Start Date	2024-12-02
Primary Completion	2025-06-23 (estimated)
Study Completion	2025-07-02 (estimated)
Updated on ClinicalTrials.gov	2025-04-11